cerrar
Tagged with MS

Interview with Dorthe Mikkelsen, Senior VP, MSD Denmark
Why did MSD decide to have Denmark as the headquarters for the Mid Europe 2 region? This Mid Europe 2 region consists of 10 countries, most of…

Interview with Eduardo Gonzalez Pier, Financial Director, IMSS…
IMSS is a central pillar in the Mexican healthcare system, covering all Mexicans working for the declared formal private sector. How do you assess the…

Interview with Patrick Bergstedt, President, Asia Pacific, MSD
In Q3 2012, MSD reported worldwide sales of $11.5 billion. What was the contribution that emerging markets had? From an MSD perspective, emerging…

Interview with Carlo Ciapparelli, General Manager, IMS Health…
Looking at your background, we see that you have been with IMS for over 12 years. What defines your loyalty to the company? What appeals most to you…

Interview with Tomáš Matějovský, Partner, CMS Cameron…
Mr. Matějovský, let's begin our discussion with a very simple question. The Czech Republic is quite a small country, and yet it seems to have…

Interview with Vlad Hogenhuis, Managing Director -Belgium &…
It truly seems that you have pharma in your genes, with a father who successfully developed a migraine drug in addition to your 4 years practicing…

Interview with Václav Novotný , Managing Director, MSD Czech…
Dr. Novotný, in 2008, you became Managing Director for MSD for the Czech and Slovak Republics. In the very next year after your appointment,…

Interview with Michael Azrak, Managing Director, MSD South Africa
If we take a look at MSD’s international presence, the group has grown into the third largest pharma company in the world. Here in South Africa,…

Interview with Steve Warner, Managing Director, Merck Sharp…
You have only just arrived from Korea to head the Romanian operations at MSD. Just recently, you told in an interview with Medica Academica that MSD…

Interview with Nilton Paletta, President, Latin America, IMS…
We know the raw data already in the Brazilian market and the number changes since our last visit in 2007 – but how would you interpret these…

Interview with Ewe Kheng Huat, Managing Director, Merck Sharp…
Stefan Oschmann, President of the Emerging Markets at Merck and Co. described MSD as the dark horse of the emerging markets. How is MSD performing in…

Interview with Tim Daveler, General Manager, MSD Mexico
We read in an article by El Economista last year that you believe “there is no other company with such a diverse range of therapies as MSD and…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here